<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51079-433-20
</NDCCode>
<PackageDescription>
100 BLISTER PACK in 1 CARTON (51079-433-20) > 1 TABLET in 1 BLISTER PACK (51079-433-01)
</PackageDescription>
<NDC11Code>
51079-0433-20
</NDC11Code>
<ProductNDC>
51079-433
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Triamterene And Hydrochlorothiazide
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Triamterene And Hydrochlorothiazide
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
19981026
</StartMarketingDate>
<EndMarketingDate>
20210831
</EndMarketingDate>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA019129
</ApplicationNumber>
<LabelerName>
Mylan Institutional Inc.
</LabelerName>
<SubstanceName>
TRIAMTERENE; HYDROCHLOROTHIAZIDE
</SubstanceName>
<StrengthNumber>
75; 50
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2021-09-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
19981026
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20210831
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>